Related Experiment Video
Updated: Oct 29, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness
Haritha Mathsyaraja1, Jonathen Catchpole1, Brian Freie1
1Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Abstract:
MGA, a transcription factor and member of the MYC network, is mutated or deleted in a broad spectrum of malignancies. As a critical test of a tumor suppressive role, we inactivated Mga in two mouse models of non-small cell lung cancer using a CRISPR-based approach. MGA loss significantly accelerated tumor growth in both models and led to de-repression of non-canonical Polycomb ncPRC1.6 targets, including genes involved in metastasis and meiosis. Moreover, MGA deletion in human lung adenocarcinoma lines augmented invasive capabilities. We further show that MGA-MAX, E2F6, and L3MBTL2 co-occupy thousands of promoters and that MGA stabilizes these ncPRC1.6 subunits. Lastly, we report that MGA loss also induces a pro-growth effect in human colon organoids. Our studies establish MGA as a bona fide tumor suppressor in vivo and suggest a tumor suppressive mechanism in adenocarcinomas resulting from widespread transcriptional attenuation of MYC and E2F target genes mediated by MGA-MAX associated with a non-canonical Polycomb complex.
Insights
MGA acts as a tumor suppressor by regulating gene expression. Its loss accelerates cancer growth and increases invasiveness in lung and colon cancers.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MGA is a transcription factor within the MYC network, frequently altered in various cancers.
- Its precise role as a tumor suppressor in vivo remains to be fully elucidated.
Purpose of the Study:
- To investigate the in vivo tumor suppressive function of MGA in non-small cell lung cancer.
- To determine the molecular mechanisms underlying MGA's role in cancer progression.
Main Methods:
- CRISPR-based inactivation of the Mga gene in mouse models of non-small cell lung cancer.
- Analysis of gene expression changes, focusing on non-canonical Polycomb targets.
- Assessment of invasive capabilities in human lung adenocarcinoma cell lines and human colon organoids.
Main Results:
- MGA loss significantly accelerated tumor growth in mouse models.
- MGA deficiency led to the de-repression of ncPRC1.6 targets involved in metastasis and meiosis.
- MGA deletion enhanced invasive properties of human lung cancer cells and promoted growth in colon organoids.
Conclusions:
- MGA functions as a bona fide tumor suppressor in vivo.
- MGA's tumor suppressive mechanism involves transcriptional attenuation of MYC and E2F targets via the MGA-MAX/ncPRC1.6 complex.
More Related Videos
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...